Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Kingchem
301509
5
Hunan Er-kang Pharmaceutical
300267
CN Stock MarketDetailed Quotes
000510 Sichuan Xinjinlu Group
- 6.61
- +0.60+9.98%
Not Open Apr 24 15:00 CST
4.29BMarket Cap-34.79P/E (TTM)
6.61High6.05Low1.07MlotVolume6.20Open6.01Pre Close698.39MTurnover17.69%Turnover RatioLossP/E (Static)648.54MShares6.6152wk High3.15P/B4.01BFloat Cap2.6352wk Low6.61Limit Up606.66MShs Float15.78Historical High5.41Limit Down9.32%Amplitude0.60Historical Low--Dividend TTM6.51Avg Price677.46KlotAsk--Div YieldTTM100Lot Size380.27KlotBid
Sichuan Xinjinlu Group Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | 1.69%224.32M | 40.55%236.21M | -19.75%135.22M | -20.51%324.37M | -2.42%220.59M | -64.01%168.06M | -57.04%168.51M | -21.99%408.05M | -11.58%226.07M | 195.14%466.89M |
| Notes receivable and accounts receivable | -0.40%118.31M | -22.43%67.11M | 2.24%134.3M | 83.78%80.1M | 4.23%118.79M | -1.29%86.51M | 106.25%131.36M | 378.28%43.58M | 188.51%113.97M | 184.52%87.63M |
| -Notes receivable | 25.86%42.89M | 13.33%1.7M | 13.27%43.3M | -37.64%6M | 19.17%34.08M | -95.03%1.5M | 2,022.46%38.23M | --9.62M | 485.30%28.6M | 112.14%30.21M |
| -Accounts receivable | -10.97%75.42M | -23.06%65.41M | -2.28%91M | 118.19%74.1M | -0.78%84.71M | 48.04%85.01M | 50.49%93.13M | 272.69%33.96M | 146.63%85.38M | 246.78%57.42M |
| Other receivables (including interest and dividends) | -54.44%35.66M | -52.37%34.69M | -32.94%39.42M | -39.45%34.65M | 59.44%78.26M | 560.95%72.84M | 531.95%58.78M | 573.73%57.22M | 263.20%49.08M | -69.40%11.02M |
| -Other receivable | ---- | -52.37%34.69M | ---- | ---- | ---- | 560.95%72.84M | ---- | 573.73%57.22M | ---- | -69.40%11.02M |
| Contractual assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Advance payment | 132.58%109.87M | 5.34%64.2M | -36.02%53.64M | 67.07%44.88M | -26.10%47.24M | -57.37%60.95M | 47.35%83.84M | -13.78%26.87M | 44.17%63.93M | 527.94%142.95M |
| Inventories | 67.17%345.23M | 39.31%329.35M | 45.86%347.63M | 39.17%318.72M | -6.54%206.51M | -9.11%236.42M | -7.52%238.33M | 18.15%229.01M | 14.62%220.96M | 53.46%260.13M |
| Receivable financing | -19.07%20.23M | -23.81%27.8M | -71.89%10.89M | -51.12%19.96M | -43.51%24.99M | -44.19%36.49M | -67.65%38.74M | -50.07%40.84M | -72.88%44.24M | -49.76%65.38M |
| Assets held for sale | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Non-current assets due within one year | --813.98K | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Other current assets | 20.83%15.56M | 34.52%12.15M | 44.11%18.42M | 50.96%16.47M | 22.67%12.88M | -9.75%9.03M | 14.56%12.78M | 16.91%10.91M | 6.45%10.5M | 18.15%10M |
| Total current assets | 22.66%869.99M | 15.10%771.51M | 0.98%739.52M | 2.78%839.16M | -2.67%709.27M | -35.80%670.29M | -19.59%732.33M | -4.71%816.49M | 0.34%728.75M | 85.16%1.04B |
| Non Current assets | ||||||||||
| Other equity investment | 0.11%99.06M | 3.35%102.27M | 8.62%102.27M | 8.62%102.27M | 12.50%98.95M | 12.50%98.95M | 7.05%94.15M | 7.05%94.15M | 56.73%87.95M | 56.73%87.95M |
| Other non-current financial assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Investment real estate | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Long-term equity investment | -58.43%30.96M | -57.85%30.95M | -58.57%29.83M | -14.53%63.65M | -2.98%74.48M | -3.31%73.41M | -10.46%72M | -5.01%74.47M | -7.01%76.77M | 31.69%75.93M |
| Fixed assets | ---- | -5.41%1.03B | ---- | ---- | ---- | 10.78%1.09B | ---- | 4.03%1.03B | ---- | 0.15%980.42M |
| Constru in process | ---- | 1.34%108.55M | ---- | ---- | ---- | 64.62%107.11M | ---- | 65.04%97.82M | ---- | 143.40%65.07M |
| Construction materials | ---- | -83.16%666.11K | ---- | ---- | ---- | -66.30%3.95M | ---- | -97.08%193.72K | ---- | 18,341.78%11.73M |
| Productive biological assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Oil and gas assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Intangible assets | -48.88%175.85M | -49.34%176.28M | 191.44%177.64M | 192.71%180.09M | 538.36%343.99M | 537.51%347.95M | 10.75%60.95M | 10.60%61.52M | -4.34%53.89M | -4.56%54.58M |
| Development expenditure | -67.27%2.81M | -68.30%2.67M | -91.40%702.4K | ---- | 58.89%8.57M | 63.18%8.41M | 116.97%8.17M | 1,080.67%8.12M | 340.15%5.4M | --5.15M |
| Goodwill | ---- | ---- | ---- | ---- | --5.53M | --5.53M | ---- | --0 | ---- | ---- |
| Long deferred expense | 345.45%92.02M | 383.24%94.52M | 432.07%93.47M | 458.63%95.16M | 289.37%20.66M | 422.66%19.56M | 320.09%17.57M | 428.69%17.03M | 48.01%5.31M | -7.92%3.74M |
| Deferred tax assets | 20.80%78.4M | 21.85%78.52M | 269.67%79.42M | 237.47%79.2M | 219.93%64.89M | 269.89%64.44M | 23.32%21.48M | 34.72%23.47M | 133.33%20.28M | 100.40%17.42M |
| Usufruct assets | -26.70%4.13M | -22.98%6.41M | -15.50%7.93M | -8.69%9.35M | -52.81%5.64M | -40.69%8.33M | 17.59%9.39M | 25.24%10.24M | 842.84%11.94M | 861.48%14.04M |
| Other non current assets | -51.62%41.32M | -25.73%48.05M | -73.29%69.81M | -10.42%63.04M | -49.50%85.41M | -60.72%64.69M | 424.40%261.4M | 337.92%70.37M | 734.96%169.13M | 1,162.55%164.68M |
| Total non current assets | -12.29%1.66B | -11.24%1.68B | -0.16%1.68B | 17.69%1.75B | 25.41%1.9B | 27.53%1.89B | 24.03%1.68B | 12.41%1.48B | 21.40%1.51B | 22.98%1.48B |
| Total assets | -2.78%2.53B | -4.34%2.45B | 0.19%2.42B | 12.40%2.58B | 16.28%2.61B | 1.35%2.56B | 6.50%2.41B | 5.67%2.3B | 13.64%2.24B | 42.81%2.52B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Short term loan | -8.99%256.17M | 28.76%255.99M | -15.32%252.73M | 44.31%291.38M | 43.68%281.46M | -32.58%198.81M | 37.08%298.45M | -5.72%201.91M | -0.56%195.9M | 114.19%294.89M |
| Notes payable and accounts payable | -15.11%338.38M | -16.17%361.62M | 35.74%453.58M | 96.27%462.98M | 26.75%398.62M | -2.12%431.35M | -8.40%334.16M | -8.80%235.89M | 41.75%314.5M | 76.00%440.68M |
| -Notes payable | -44.17%78.15M | -31.19%67.07M | 36.49%116.67M | 273.53%174.34M | 15.17%139.98M | -55.39%97.47M | -47.34%85.48M | 39.87%46.67M | 83.07%121.54M | 239.52%218.48M |
| -Accounts payable | 0.62%260.23M | -11.78%294.55M | 35.48%336.91M | 52.55%288.64M | 34.04%258.63M | 50.27%333.88M | 22.82%248.67M | -16.00%189.21M | 24.11%192.96M | 19.44%222.19M |
| Contract liabilities | 65.63%81.97M | 26.37%88.46M | -51.08%40.19M | -23.17%42.5M | -35.41%49.49M | -37.54%70M | 30.86%82.15M | 26.97%55.32M | -24.52%76.62M | 242.62%112.08M |
| Advance receipts | -88.22%266.97K | ---- | -74.13%310.5K | -9.00%1.88M | 191.89%2.27M | -33.43%558.3K | 7.30%1.2M | 4.72%2.07M | --776.12K | --838.71K |
| Salaries payable | -32.94%18.8M | -46.93%13.89M | 8.71%16.28M | -13.65%52.57M | -50.44%28.03M | -25.21%26.17M | -2.71%14.97M | -46.39%60.88M | -31.40%56.56M | -22.00%34.99M |
| Taxs payable | 13.73%11.03M | -22.52%8.33M | -30.13%6.8M | -89.20%3.21M | -23.51%9.7M | -55.80%10.75M | -72.24%9.74M | -34.68%29.74M | -72.64%12.68M | -30.98%24.32M |
| Other payable (including interest and dividends) | -48.36%71.25M | -47.81%69.81M | 137.37%75.5M | 106.67%70.52M | 367.41%137.97M | 340.94%133.76M | -17.63%31.81M | -1.71%34.12M | -19.63%29.52M | -12.79%30.33M |
| -Dividend payable | 0.00%190.97K | 0.00%190.97K | 0.00%190.97K | 0.00%190.97K | 0.00%190.97K | 0.00%190.97K | 0.00%190.97K | 0.00%190.97K | 0.00%190.97K | 0.00%190.97K |
| -Other payable | ---- | -47.88%69.62M | ---- | ---- | ---- | 343.10%133.57M | ---- | -1.72%33.93M | ---- | -12.51%30.14M |
| Non current liabilities due within one year | 9.29%81.24M | 84.10%100.34M | 47.83%86.9M | 59.19%100.39M | 1,249.39%74.33M | 1,130.42%54.5M | 1,597.00%58.79M | 1,720.48%63.06M | --5.51M | --4.43M |
| Other current liabilities | 65.63%10.66M | 26.37%11.5M | -51.08%5.22M | -22.80%5.53M | -35.40%6.43M | -37.54%9.1M | 29.97%10.68M | 26.37%7.16M | -24.53%9.96M | 242.62%14.57M |
| Total current liabilities | -11.99%869.75M | -2.68%909.94M | 11.35%937.51M | 49.38%1.03B | 40.78%988.3M | -2.31%935M | 12.68%841.95M | -4.32%690.16M | 0.42%702.01M | 77.28%957.14M |
| Current liabilities | ||||||||||
| Long term loan | 104.55%45M | --55M | --26M | --26M | --22M | ---- | ---- | --0 | ---- | ---- |
| Bonds payable | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Preferred stock | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Perpetual Debt | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Long term account payable | ---- | 72.47%46.6M | ---- | ---- | ---- | 8,486.39%27.02M | ---- | 14,777.90%47.36M | ---- | -22.52%314.68K |
| Estimate liabilities | --308K | --308K | --308K | --308K | ---- | ---- | ---- | ---- | ---- | ---- |
| Deferred tax liabilities | 9.30%126.84M | 8.95%126.69M | 86.25%125.96M | 84.44%125.99M | 91.44%116.05M | 83.14%116.27M | 12.35%67.63M | 26.87%68.31M | 62.24%60.62M | 77.61%63.49M |
| Long term deferred income | -3.88%32.95M | 0.78%33.85M | 17.10%34.58M | 12.79%34.36M | 8.18%34.28M | 2.30%33.59M | -12.52%29.53M | -11.78%30.46M | 57.36%31.69M | 32.27%32.84M |
| Lease liabilities | 225.87%3.57M | 116.64%3.49M | -68.15%1.76M | -23.09%3.22M | -80.08%1.1M | -79.85%1.61M | 41.55%5.54M | 3.89%4.18M | 280.15%5.5M | 447.65%8M |
| Total non current liabilities | 19.21%241.91M | 48.99%265.94M | 62.17%217.17M | 51.03%227.03M | 106.87%202.93M | 70.58%178.5M | 36.40%133.91M | 62.12%150.32M | 65.33%98.1M | 67.59%104.64M |
| Total liabilities | -6.68%1.11B | 5.60%1.18B | 18.33%1.15B | 49.68%1.26B | 48.88%1.19B | 4.87%1.11B | 15.44%975.86M | 3.25%840.48M | 5.50%800.11M | 76.27%1.06B |
| Shareholders equity | ||||||||||
| Paid-in capital | 6.46%648.54M | 0.00%609.18M | 0.00%609.18M | 0.00%609.18M | 0.00%609.18M | 0.00%609.18M | 0.00%609.18M | 0.00%609.18M | 0.00%609.18M | 0.00%609.18M |
| Other equity instruments | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| -Equity of prefer stock | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| -Equity of Perpetual debt | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Capital reserve funds | 102.95%190.94M | 12.02%105.39M | 12.02%105.39M | 12.02%105.39M | 9.09%94.08M | 50.00%94.08M | 140.00%94.08M | 500.00%94.08M | 322.24%86.24M | 207.08%62.72M |
| Surplus reserve funds | 0.00%71.35M | 0.00%71.35M | 0.00%71.35M | 0.00%71.35M | 4.78%71.35M | 4.78%71.35M | 4.78%71.35M | 4.78%71.35M | -39.06%68.1M | -39.06%68.1M |
| Retained profit | -22.93%415.74M | -31.09%391.75M | -35.81%386.83M | -28.19%449.96M | -13.58%539.43M | -14.93%568.54M | -7.14%602.62M | 1.55%626.6M | 18.23%624.18M | 39.40%668.34M |
| Less:Treasury stock | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Other composite income | 7.40%30.64M | 7.40%30.64M | 7.40%30.64M | 7.40%30.64M | 19.47%28.52M | 19.47%28.52M | 19.47%28.52M | 19.47%28.52M | --23.88M | --23.88M |
| Specific reserves | -10.73%4.31M | 2.52%4.75M | 21.44%5.35M | 17.43%3.74M | 24.26%4.83M | 23.00%4.63M | 46.73%4.4M | 39.50%3.18M | 219.82%3.88M | -10.03%3.77M |
| Shareholders equity without minority interests | 1.05%1.36B | -11.86%1.21B | -14.28%1.21B | -11.35%1.27B | -4.81%1.35B | -4.16%1.38B | 1.28%1.41B | 7.24%1.43B | 19.90%1.42B | 26.51%1.44B |
| Minority interests | -10.30%61.39M | -14.77%58.71M | 99.85%54.22M | 114.94%56.59M | 159.26%68.44M | 155.51%68.89M | -3.98%27.13M | 0.41%26.33M | -22.04%26.4M | -11.34%26.96M |
| Total shareholder equity | 0.50%1.42B | -12.00%1.27B | -12.13%1.26B | -9.07%1.33B | -1.81%1.42B | -1.21%1.45B | 1.18%1.44B | 7.11%1.46B | 18.73%1.44B | 25.52%1.46B |
| Total liabilityies and equity | -2.78%2.53B | -4.34%2.45B | 0.19%2.42B | 12.40%2.58B | 16.28%2.61B | 1.35%2.56B | 6.50%2.41B | 5.67%2.3B | 13.64%2.24B | 42.81%2.52B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Sigma Certified Public Accountants (Special General Partnership) | -- | -- | -- | Sigma Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current
Moomoo News Global
Apr 9 20:29
Learning From Buffett: Investing Wisely Amid Market Volatility Triggered by Trump's Tariffs